RCKT
Price
$10.47
Change
-$0.40 (-3.68%)
Updated
Feb 21 closing price
Capitalization
1.11B
12 days until earnings call
VYGR
Price
$4.22
Change
-$0.04 (-0.94%)
Updated
Feb 21 closing price
Capitalization
230.79M
17 days until earnings call
Ad is loading...

RCKT vs VYGR

Header iconRCKT vs VYGR Comparison
Open Charts RCKT vs VYGRBanner chart's image
Rocket Pharmaceuticals
Price$10.47
Change-$0.40 (-3.68%)
Volume$1.08M
Capitalization1.11B
Voyager Therapeutics
Price$4.22
Change-$0.04 (-0.94%)
Volume$282.62K
Capitalization230.79M
RCKT vs VYGR Comparison Chart
Loading...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCKT vs. VYGR commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCKT is a Hold and VYGR is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (RCKT: $10.87 vs. VYGR: $4.26)
Brand notoriety: RCKT and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCKT: 55% vs. VYGR: 82%
Market capitalization -- RCKT: $1.11B vs. VYGR: $230.79M
RCKT [@Biotechnology] is valued at $1.11B. VYGR’s [@Biotechnology] market capitalization is $230.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCKT’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 0 green FA rating(s).

  • RCKT’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 0 green, 5 red.
According to our system of comparison, VYGR is a better buy in the long-term than RCKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCKT’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • RCKT’s TA Score: 4 bullish, 4 bearish.
  • VYGR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both RCKT and VYGR are a good buy in the short-term.

Price Growth

RCKT (@Biotechnology) experienced а +7.41% price change this week, while VYGR (@Biotechnology) price change was -2.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

RCKT is expected to report earnings on May 07, 2025.

VYGR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($1.11B) has a higher market cap than VYGR($231M). RCKT YTD gains are higher at: -13.524 vs. VYGR (-24.868). VYGR has higher annual earnings (EBITDA): 14.1M vs. RCKT (-247.25M). VYGR has more cash in the bank: 345M vs. RCKT (236M). RCKT has less debt than VYGR: RCKT (25.6M) vs VYGR (45.3M). VYGR has higher revenues than RCKT: VYGR (164M) vs RCKT (0).
RCKTVYGRRCKT / VYGR
Capitalization1.11B231M482%
EBITDA-247.25M14.1M-1,754%
Gain YTD-13.524-24.86854%
P/E RatioN/A6.40-
Revenue0164M-
Total Cash236M345M68%
Total Debt25.6M45.3M57%
FUNDAMENTALS RATINGS
RCKT vs VYGR: Fundamental Ratings
RCKT
VYGR
OUTLOOK RATING
1..100
1068
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9758
PRICE GROWTH RATING
1..100
6589
P/E GROWTH RATING
1..100
10057
SEASONALITY SCORE
1..100
n/a40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (37) in the Biotechnology industry is in the same range as RCKT (45). This means that VYGR’s stock grew similarly to RCKT’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RCKT (100). This means that VYGR’s stock grew similarly to RCKT’s over the last 12 months.

VYGR's SMR Rating (58) in the Biotechnology industry is somewhat better than the same rating for RCKT (97). This means that VYGR’s stock grew somewhat faster than RCKT’s over the last 12 months.

RCKT's Price Growth Rating (65) in the Biotechnology industry is in the same range as VYGR (89). This means that RCKT’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (57) in the Biotechnology industry is somewhat better than the same rating for RCKT (100). This means that VYGR’s stock grew somewhat faster than RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCKTVYGR
RSI
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSCYX5.87N/A
N/A
Saratoga Small Capitalization A
MDGCX25.74N/A
N/A
BlackRock Advantage Global Investor A
PMYAX44.61N/A
N/A
Putnam Core Equity Fund A
ACVDX8.97N/A
N/A
American Century International Val R6
DFMIX35.76N/A
N/A
Davidson Multi-Cap Equity I

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with FATE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-0.46%
FATE - RCKT
53%
Loosely correlated
-9.65%
AXON - RCKT
52%
Loosely correlated
-8.70%
DNLI - RCKT
52%
Loosely correlated
-2.88%
NTLA - RCKT
52%
Loosely correlated
-0.24%
PRME - RCKT
50%
Loosely correlated
-4.72%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.93%
RGNX - VYGR
46%
Loosely correlated
-1.34%
RCKT - VYGR
43%
Loosely correlated
-0.46%
XENE - VYGR
41%
Loosely correlated
+2.29%
EDIT - VYGR
40%
Loosely correlated
-35.63%
ACLX - VYGR
39%
Loosely correlated
+3.67%
More